HomeCompareRPHM vs XYLD

RPHM vs XYLD: Dividend Comparison 2026

RPHM yields 10.99% · XYLD yields 10.98%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RPHM wins by $16.1K in total portfolio value
10 years
RPHM
RPHM
● Live price
10.99%
Share price
$18.20
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$41.3K
Annual income
$2,186.89
Full RPHM calculator →
XYLD
Global X S&P 500 Covered Call ETF
● Live price
10.98%
Share price
$39.13
Annual div
$4.30
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.3K
Annual income
$3,219.02
Full XYLD calculator →

Portfolio growth — RPHM vs XYLD

📍 RPHM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRPHMXYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RPHM + XYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RPHM pays
XYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RPHM
Annual income on $10K today (after 15% tax)
$934.07/yr
After 10yr DRIP, annual income (after tax)
$1,858.86/yr
XYLD
Annual income on $10K today (after 15% tax)
$933.63/yr
After 10yr DRIP, annual income (after tax)
$2,736.17/yr
At 15% tax rate, XYLD beats the other by $877.31/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RPHM + XYLD for your $10,000?

RPHM: 50%XYLD: 50%
100% XYLD50/50100% RPHM
Portfolio after 10yr
$33.3K
Annual income
$2,702.95/yr
Blended yield
8.12%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on RPHM right now

RPHM
Analyst Ratings
4
Buy
3
Hold
Consensus: Buy
Altman Z
-0.1
Piotroski
3/9
XYLD
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RPHM buys
0
XYLD buys
0
No recent congressional trades found for RPHM or XYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRPHMXYLD
Forward yield10.99%10.98%
Annual dividend / share$2.00$4.30
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$41.3K$25.3K
Annual income after 10y$2,186.89$3,219.02
Total dividends collected$16.4K$19.6K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: RPHM vs XYLD ($10,000, DRIP)

YearRPHM PortfolioRPHM Income/yrXYLD PortfolioXYLD Income/yrGap
1← crossover$11,799$1,098.90$10,818$1,098.39+$981.00RPHM
2$13,837$1,211.76$11,738$1,222.51+$2.1KRPHM
3$16,133$1,328.07$12,774$1,364.64+$3.4KRPHM
4$18,710$1,447.20$13,944$1,527.86+$4.8KRPHM
5$21,588$1,568.52$15,270$1,715.87+$6.3KRPHM
6$24,791$1,691.42$16,775$1,933.09+$8.0KRPHM
7$28,341$1,815.27$18,490$2,184.87+$9.9KRPHM
8$32,264$1,939.50$20,450$2,477.63+$11.8KRPHM
9$36,587$2,063.54$22,697$2,819.19+$13.9KRPHM
10$41,334$2,186.89$25,280$3,219.02+$16.1KRPHM

RPHM vs XYLD: Complete Analysis 2026

RPHMStock

Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as well as in Phase 1b clinical trial in patients with long-chain fatty acid oxidation disorders and glycogen storage disease type V. Reneo Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

Full RPHM Calculator →

XYLDETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →
📬

Get this RPHM vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RPHM vs SCHDRPHM vs JEPIRPHM vs ORPHM vs KORPHM vs MAINRPHM vs QYLDRPHM vs JEPQRPHM vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.